Karen rolton, Sports venue in Adelaide city centre, Australia

New Delhi, Nov 1 Australia on Monday recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine.The Therapeutic Goods Administration (TGA), the Australian drug regulator, announced that it has recognised two more Covid-19 vaccines not registered in Australia but used widely internationally, which includes Bharat Biotech's Covaxin and BBIBP-CorV (manufactured by Sinopharm, China)."This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV," the TGA said in a statement.The TGA further stated that with recognition of Covaxin, and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India), means many citizens of India and China as well as other countries in the region where these vaccines have been widely deployed will now be considered fully vaccinated on entry to Australia."This will have significant impact for the return of international students, and travel of skilled and unskilled workers to Australia," it said.The TGA mentioned that in recent weeks it has obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit Covid-19 infection to others while in Australia or become acutely unwell due to Covid-19."The supporting information has been provided to the TGA from the vaccine sponsor and or the World Health Organisation (WHO)," it said.In addition, with input from the TGA, Australian Technical Advisory Group on Immunisation (ATAGI) (ATAGI) have determined that those who have received two doses of a TGA-approved or recognised vaccine at least 14 days apart are regarded as fully vaccinated from seven days after the second dose (with the exception of Janssen vaccine, where they are regarded as fully vaccinated seven days after the single dose). This includes homologous (two doses of the same vaccine) and heterologous (two doses of two different TGA-approved or recognised vaccines) schedules."From 1 November 2021, vaccinated Austral and permanent residents aged 12 and over may depart Australia without the need to seek a travel exemption," the statement added.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Karen RoltonFOLLOW

Karen rolton, Latest News

Dubai, Nov 4 Adam Zampa shined with a five-wicket haul as Australia decimated a hapless Bangladesh by eight ... ...

Dubai, Nov 4 Australia made short work of a small chase to beat Bangladesh by eight wickets in ... ...

Australian fast bowler James Pattinson said that he is thankful to have the opportunity to represent his country in international cricket but he cannot push his body any further to play Test cricket again. ...

Canberra, Nov 3 Australian Prime Minister Scott Morrison on Wednesday greeted Ind living there on the occasion of ... ...

Dubai, Nov 3 Jos Buttler's hammering would have rattled one of the title favourites Australia in the ICC ... ...

Pooja Advani's day begins with her checking up on her guests. Then comes the bitter-sweet bit - check-ins and checkouts. Waving goodbye to those who've come to become friends, and saying hello to new and enthusiastic wet noses and wagging tails. ...

Australian government on Monday gave recognition to Bharat Biotech's Covaxin COVID-19 vaccine for the purpose of establishing a traveller's vaccination status in the country. ...

New Delhi, Nov 1 Australia on Monday recognised Bharat Biotech's Covaxin for allowing entry of travellers who had ... ...